MetaADEDB 2.0 @ LMMD
Jalyn
(SHHCJPKACHSWFP-NMXGMQNUSA-N)
Structure
SMILES
O=C1C=C[C@]2([C@H](N1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@H]2C(=O)Nc1cc(ccc1C(F)(F)F)C(F)(F)F)C)C.CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C
Molecular Formula:
C47H58F6N4O7S
Molecular Weight:
937.041
Log P:
11.4908
Hydrogen Bond Acceptor:
11
Hydrogen Bond Donor:
4
TPSA:
166.46
CAS Number(s):
N/A
Synonym(s)
1.
Jalyn
External Link(s)
PubChem Compound11679580
Therapeutic Target DatabaseD09JFY
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 17US FAERS
2Erectile dysfunctionFAERS: 15US FAERS
3DizzinessFAERS: 12US FAERS
4Breast tendernessFAERS: 6US FAERS
5HeadacheFAERS: 6US FAERS
6PruritusFAERS: 6US FAERS
7Cerebrovascular accidentFAERS: 5US FAERS
8NocturiaFAERS: 5US FAERS
9DyspepsiaFAERS: 4US FAERS
10Retrograde ejaculationFAERS: 4US FAERS
11Semen volume decreasedFAERS: 4US FAERS
12Adverse eventFAERS: 3US FAERS
13AstheniaFAERS: 3US FAERS
14Back PainFAERS: 3US FAERS
15Drug administration errorFAERS: 3US FAERS
16Drug dose omissionFAERS: 3US FAERS
17DysuriaFAERS: 3US FAERS
18FatigueFAERS: 3US FAERS
19HypersensitivityFAERS: 3US FAERS
20HypotensionFAERS: 3US FAERS
21Therapeutic response unexpectedFAERS: 3US FAERS
22Urinary RetentionFAERS: 3US FAERS
23AmnesiaFAERS: 2US FAERS
24AneurysmFAERS: 2US FAERS
25ArthralgiaFAERS: 2US FAERS
26Benign Prostatic HyperplasiaFAERS: 2US FAERS
27Chest PainFAERS: 2US FAERS
28ChillsFAERS: 2US FAERS
29Completed SuicideFAERS: 2US FAERS
30Feeling abnormalFAERS: 2US FAERS
31HemiplegiaFAERS: 2US FAERS
32MalaiseFAERS: 2US FAERS
33Myocardial InfarctionFAERS: 2US FAERS
34NauseaFAERS: 2US FAERS
35PainFAERS: 2US FAERS
36Product quality issueFAERS: 2US FAERS
37SepsisFAERS: 2US FAERS
38Skin UlcerFAERS: 2US FAERS
39SomnolenceFAERS: 2US FAERS
40SwellingFAERS: 2US FAERS
41SyncopeFAERS: 2US FAERS
42Urethritis noninfectiveFAERS: 2US FAERS
43AbasiaFAERS: 1US FAERS
44Accidental exposure to productFAERS: 1US FAERS
45Animal biteFAERS: 1US FAERS
46Aortic AneurysmFAERS: 1US FAERS
47AphagiaFAERS: 1US FAERS
48AphasiaFAERS: 1US FAERS
49Arthropod biteFAERS: 1US FAERS
50Bladder spasmFAERS: 1US FAERS
51Blood glucose increasedFAERS: 1US FAERS
52Blood triglycerides increasedFAERS: 1US FAERS
53Cataract operationFAERS: 1US FAERS
54Choking sensationFAERS: 1US FAERS
55CholelithiasisFAERS: 1US FAERS
56Congenital cystic kidney diseaseFAERS: 1US FAERS
57Contracted bladderFAERS: 1US FAERS
58DeafnessFAERS: 1US FAERS
59DementiaFAERS: 1US FAERS
60Dermatitis HerpetiformisFAERS: 1US FAERS
61Diabetes MellitusFAERS: 1US FAERS
62Drug prescribing errorFAERS: 1US FAERS
63DysgeusiaFAERS: 1US FAERS
64EpistaxisFAERS: 1US FAERS
65Expired product administeredFAERS: 1US FAERS
66Exposure via body fluidFAERS: 1US FAERS
67Eye irritationFAERS: 1US FAERS
68FlatulenceFAERS: 1US FAERS
69General physical health deteriorationFAERS: 1US FAERS
70GlaucomaFAERS: 1US FAERS
71Head discomfortFAERS: 1US FAERS
72High density lipoprotein increasedFAERS: 1US FAERS
73Intestinal PerforationFAERS: 1US FAERS
74Joint swellingFAERS: 1US FAERS
75LabyrinthitisFAERS: 1US FAERS
76Lichen PlanusFAERS: 1US FAERS
77Medication residueFAERS: 1US FAERS
78Medication residue presentFAERS: 1US FAERS
79Middle insomniaFAERS: 1US FAERS
80Multiple allergiesFAERS: 1US FAERS
81Multiple drug therapyFAERS: 1US FAERS
82Musculoskeletal PainFAERS: 1US FAERS
83MyalgiaFAERS: 1US FAERS
84MydriasisFAERS: 1US FAERS
85NasopharyngitisFAERS: 1US FAERS
86Nipple painFAERS: 1US FAERS
87Oral mucosal eruptionFAERS: 1US FAERS
88Oral painFAERS: 1US FAERS
89Oropharyngeal painFAERS: 1US FAERS
90PalpitationsFAERS: 1US FAERS
91PancreatitisFAERS: 1US FAERS
92Personality ChangeFAERS: 1US FAERS
93PneumoniaFAERS: 1US FAERS
94Polymyalgia RheumaticaFAERS: 1US FAERS
95Product substitution issueFAERS: 1US FAERS
96Product use in unapproved indicationFAERS: 1US FAERS
97Retinal exudatesFAERS: 1US FAERS
98Semen viscosity abnormalFAERS: 1US FAERS
99Semen volume abnormalFAERS: 1US FAERS
100Sexual DysfunctionFAERS: 1US FAERS
101Sperm concentration zeroFAERS: 1US FAERS
102Suture insertionFAERS: 1US FAERS
103Therapy cessationFAERS: 1US FAERS
104TinnitusFAERS: 1US FAERS
105Tongue blisteringFAERS: 1US FAERS
106ToothacheFAERS: 1US FAERS
107Urinary tract infectionFAERS: 1US FAERS
108Urine flow decreasedFAERS: 1US FAERS
109UrticariaFAERS: 1US FAERS
110VertigoFAERS: 1US FAERS
111Vulvovaginal discomfortFAERS: 1US FAERS
112Weight decreasedFAERS: 1US FAERS
113Wrong technique in drug usage processFAERS: 1US FAERS
114Wrong technique in product usage processFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.